PubGene has signed an innovation contract with the medical clinic Moloklinikken AS. The main objective is to define, develop and streamline the Coremine Vitae biomedical intelligence report as a combined personalised medicine information tool and service. Working with a private clinic like Moloklinikken provides an efficient opportunity to design a new product, since they play a key role in adapting new technologies, tools and solutions in healthcare service in general, and the cancer treatment workflow in particular. The core value for Moloklinikken is to provide novel technology and service for their patients. The innovation contract project is funded by Innovation Norway.